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Abstract
Background
Traditionally, basal rate profiles in continuous subcutaneous insulin infusion therapy are
individually adapted to cover expected insulin requirements. However, whether this
approach is indeed superior to a more constant BR profile has not been assessed so far.
This study analysed the associations between variability of BR profiles and acute and
chronic complications in adult type 1 diabetes mellitus.
Materials and Methods
BR profiles of 3118 female and 2427 male patients from the “Diabetes-Patienten-Verlaufs-
dokumentation” registry from Germany and Austria were analysed. Acute and chronic com-
plications were recorded 6 months prior and after the most recently documented basal rate.
The “variability index” was calculated as variation of basal rate intervals in percent and
describes the excursions of the basal rate intervals from the median basal rate.
Results
The variability Index correlated positively with severe hypoglycemia (r = .06; p<0.001),
hypoglycemic coma (r = .05; p = 0.002), and microalbuminuria (r = 0.05; p = 0.006). In addi-
tion, a higher variability index was associated with higher frequency of diabetic ketoacidosis
(r = .04; p = 0.029) in male adult patients. Logistic regression analysis adjusted for age, gen-
der, duration of disease and total basal insulin confirmed significant correlations of the vari-
ability index with severe hypoglycemia (β = 0.013; p<0.001) and diabetic ketoacidosis (β =
0.012; p = 0.017).
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Conclusions
Basal rate profiles with higher variability are associated with an increased frequency of
acute complications in adults with type 1 diabetes.
Introduction
While much attention has been attributed to the adjustment of bolus insulin doses to carbohy-
drate consumption, physical activity, and pre-meal blood glucose concentrations in continuous
subcutaneous insulin infusion therapy (CSII), considerably less is known regarding individual
basal insulin requirements.[1] However, improper basal insulin programming may cause unde-
sirable glucose excursions between meals, under fasting conditions and during sleep as well as
difficulties achieving euglycemia during exercise.[2] For example, it has recently been shown
that programming CSII with increasing insulin delivery overnight to counteract the dawn phe-
nomenon may be less effective than expected and may even increase the risk for hypoglycemia.
[3] To the best of our knowledge, no studies are available that compare the effectiveness
between circadian and flat basal rate programming strategies to improve glycemic control in
adult type 1 diabetic patients.
The aim of this study was to identify the associations between basal rate variability and
acute or chronic complications. Although basal rates and glucose profiles are intrinsically indi-
vidual, identifying an association between basal insulin variation and acute or chronic compli-
cations could extend our knowledge on basal rate programming.
Materials and Methods
Patients
Data from the DPV-Wiss-database, a standardized, prospective, computer-based documenta-
tion of diabetes care and clinical outcomes, were analyzed. During 1995–2014, 5545 adult
patients (3118 women, 2374 men) aged18 years with type 1 diabetes were documented from
420 centers in Germany and Austria. Inconsistent data were reported back to the centers every
6 months for correction. Data collection was approved by the institutional review board at Ulm
University and the local diabetes centers and is in accordance with the Declaration of Helsinki.
Data collection in the DPV-Wiss-database is in compliance with the hospital data-protection
agencies in all participating centers. Only anonymous data are transmitted for centralized anal-
ysis at the Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany.
Variables evaluated were the “variability index” (VI) of basal rates, gender, age at last visit,
height, weight, body mass index (defined as body weight in kilograms (kg) divided by square of
height in meters), diabetes duration, total daily insulin dose, insulin dose per kg, total daily
basal insulin dose, basal insulin dose per kg, prevalent diabetic retinopathy, severe hypoglyce-
mia (defined as hypoglycemia requiring third party help), coma induced by hypoglycemia, and
diabetic ketoacidosis (defined as hospital admission due to ketoacidosis with hyperglycemia
>11 mmol/L and pH<7.3), prevalent microalbuminuria, and prevalent macroalbuminuria.
The VI was calculated as variation of BR intervals in percent, describing the excursions of the
BR profile. From each BR profile the smallest BR (> zero units) was taken as the reference BR.
Next, difference in percent was calculated for each BR before and after the reference BR, added
and divided by the number of BR-intervals (24 per day). Using local HbA1c reference values,
HbA1c levels were mathematically standardized to the DCCT reference (range 4.05–6.05%) by
means of the ‘multiple of the mean’ method to adjust for different laboratory methods.
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For each patient, mean or median values of data from the most recent year of diabetes care
were used for analysis. Regarding basal rate variation, the most recent basal rate was used. Fol-
lowing the architecture of the DPV registry, hourly basal rates (24 basal rates per day) were
used for calculation. Acute (severe hypoglycemia, hypoglycemic coma and diabetic ketoacido-
sis) and chronic (diabetic retinopathy, micro and macro albuminuria) address a time frame
of ± 6 months from the most recent basal rate.
Statistical analysis
Calculations were done in the whole population and stratified by sex. Descriptive statistics
(mean, standard deviation (SD), median, lower and upper quartile) were calculated for all vari-
ables. Spearman correlation coefficient with Fisher´s z transformation was used to calculate
associations between diabetic complications, insulin doses, anthropometric measurements and
BR variability. Linear regression analysis adjusted for the confounding factors age, gender,
duration of diabetes, and basal rate per kg body weight was used to analyze the association
between BR variability and diabetic complications. Furthermore, logistic regression models
were run to estimate the association between basal rate variability, HbA1c and BMI. In regres-
sion analyses, VI was first included either as a continuous variable and subsequently catego-
rized; F-tests or Wald tests were used to test for significance. Data from regression analysis
using VI quartiles were used to construct Forest plots illustrating the odds ratio per quartile for
the development of the influence on several endpoints. For all tests, a p-value of less than 0.05
was considered significant. Statistical analysis was carried out with SAS Version 9.4 (SAS Insti-
tute Inc., Cary, NC, USA) (17).
Results
Descriptive characteristics of the study cohort are illustrated in Table 1, results of spearman
rho correlations coefficient are shown in Table 2, and Table 3 illustrates results of linear regres-
sion analysis. Fig 1 illustrates the odds ratio for each VI quartile on acute complications derived
Table 1. Patient characteristics, separated into total cohort, women andmen. N = 5545
Total cohort, n = 5545 Women, n = 3118 Men, n = 2427
Mean ± STD Mean ± STD Mean ± STD
Variability index (%) 27.77 12.96 27.26 13.15 28.42 12.69
Age (years) 33.28 16.23 33.14 15.78 33.47 16.79
Duration of disease (years) 17.31 12.06 17.31 11.76 17.31 12.43
BMI (kg/m2) 25.51 4.39 25.74 4.57 25.23 4.15
Total daily insulin dose (IU) 71.77 30.18 66.48 28.52 78.57 30.88
Insulin dose/kg (IU) 0.96 0.37 0.94 0.37 0.98 0.36
Bolus Insulin dose/kg (IU) 0.39 0.20 0.37 0.20 0.41 0.20
Basal Insulin dose/kg (IU) 0.59 0.23 0.59 0.24 0.60 0.28
Total daily BR/24h (IU) 44.49 19.73 41.81 18.77 47.92 20.39
BR/kg/24h (IU) 0.59 0.23 0.59 0.24 0.60 0.23
HbA1c (%) 7.99 1.61 7.94 1.56 8.07 1.66
SMBG/24h 5.08 1.86 5.18 1.88 4.95 1.83
Data presented as mean ± standard deviation. Variability index indicates variation coefﬁcient in basal rate intervals (%). Abbreviations: STD = standard
deviation; kg = kilograms; m = meter; IU = international units; BR = basal rates; HbA1c = glycated hemoglobin; SMBG = self-monitoring of blood glucose
doi:10.1371/journal.pone.0150604.t001
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from a multivariable logistic regression model. For a complete list of odds ratios for VI quar-
tiles on several acute and chronic endpoints please refer to supplemental material (S1 Fig).
In total, 5545 patients including 3118 female and 2427 male adult patients entered data
analysis. Mean age ± SD was 33.3 ± 16.2 years; mean duration of diabetes was 17.3 ± 12.1.
Mean total insulin dose was 71.8 ± 30.2 international units (IU); mean total daily basal rate was
44.5 ± 19.7 IU. Mean prandial insulin dose was 0.39 ± 0.20 IU per kilogram (kg). Female
patients used 0.37 ± 0.20 IU per kg, while male patients used 0.41 ± 0.20 IU per kg. Mean basal
insulin dose per kg was 0.59 ± 0.23. Female patients used 0.59 ± 0.24 IU per kg, while male
patients used 0.60 ± 0.28 IU per kg. Mean percentage of glycated hemoglobin was 7.99 ± 1.61%
in the entire cohort, 7.94 ± 1.56% for female patients, and 8.07 ± 1.66% for male patients,
respectively. The number of blood glucose measurements (self-monitoring of blood glucose
(SMBG)) was 5.18 ± 1.88 for female patients and 4.95 ± 1.83 for male patients per day, respec-
tively. Mean variability in basal rate was 27.8 ± 12.9% for the entire cohort, 27.24 ± 13.16% for
female patients, and 28.41 ± 12.69% for male patients, respectively.
Severe hypoglycemia was diagnosed in 357 (6.4%) patients. Of these, 190 (3.4%) patients
experienced hypoglycemic coma. Diabetic ketoacidosis was found in 218 (3.9%) patients. Dia-
betic retinopathy was found in 573 (10.4%) patients, proliferative retinopathy was found in 258
Table 2. Correlations of variability index with acute and chronic complications as well as patient’s characteristics in adult type 1 diabetic patients.
N = 5545.
Variability indexA Variability index ♀ Variability index ♂
Severe hypoglycemia (y/n)B 0.059 p = 0.002 0.058 p = 0.001 0.050 p = 0.004
Diabetic ketoacidosis (y/n) 0.025 p = 0.068 0.013 p = 0.469 0.044 p = 0.029
Hypoglycemic coma (y/n) 0.041 p<0.001 0.032 p = 0.071 0.058 p = 0.013
Microalbuminuria (%) 0.045 p = 0.006 0.036 p = 0.101 0.046 p = 0.058
Macroalbuminuria (%) 0.015 p = 0.362 0.015 p = 0.421 0.006 p = 0.797
Retinopathy (%) 0.029 p = 0.135 0.031 p = 0.218 0.006 p = 0.399
Proliferative retinopathy (%) 0.031 p = 0.109 0.051 p = 0.044 0.006 p = 0.847
Sex (male) 0.059 p<0.001 n.a. n.a. n.a. n.a.
Age (years) 0.228 p<0.001 0.196 p<0.001 0.266 p<0.001
Duration of disease (years) 0.067 p<0.001 0.044 p = 0.013 0.097 p<0.001
Body weight (kg) 0.015 p = 0.265 -0.042 p = 0.021 0.053 p = 0.010
BMI (kg/m2) 0.056 p<0.001 0.001 p = 0.938 0.132 p<0.001
Total daily insulin dose (IU) -0.223 p<0.001 -0.239 p<0.001 -0.244 p<0.001
Bolus Insulin dose/kg (IU) -0.098 p<0.001 -0.069 p<0.001 -0.153 p<0.001
Basal Insulin dose/kg (IU) -0.324 p<0.001 -0.323 p<0.001 -0.328 p<0.001
Insulin dose/kg (IU) -0.273 p<0.001 -0.261 p<0.001 -0.298 p<0.001
Total daily BR/24h (IU) -0.269 p<0.001 -0.296 p<0.001 -0.264 p<0.001
BR/kg/24h (IU) -0.324 p<0.001 -0.324 p<0.001 -0.327 p<0.001
HbA1c (%) -0.127 p<0.001 -0.111 p<0.001 -0.153 p<0.001
SMBG/24h 0.041 p = 0.004 0.043 p = 0.024 0.048 p = 0.029
Variability index indicates variation in basal rate intervals (%), bold areas indicate signiﬁcant correlations.
A = upper line illustrates spearman´s rho, lower line illustrates the test probability.
B = severe hypoglycemia was blood glucose concentrations <70milligrams/deciliter + requirement of outside assistance.
Abbreviations: n.a. = not applicable; BR = basal rates; kg = kilograms; m = meter; IU = international unit; h = hours; y = yes; n = no; HbA1c = glycated
hemoglobin; SMBG = self-monitoring of blood glucose
doi:10.1371/journal.pone.0150604.t002
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(4.6%) micro- and macroalbuminuria was diagnosed in 547 (9.9%) and 80 (1.4%) patients,
respectively.
Basal rate variability was positively correlated with severe hypoglycemia (p<0.001), hypo-
glycemic coma (p = 0.002), and microalbuminuria (p = 0.006). In addition, VI positively corre-
lated with age (p<0.001), duration of diabetes (p<0.0001), body height (p = 0.021), and BMI
(p<0.0001), and SMBG (p = 0.004)but negatively with total daily insulin (p<0.001), insulin
dose per kg (p<0.001), total daily basal rate (p<0.0001), basal rate per kg (p<0.001), and bolus
dose per kg (p>0.001).
Table 3. Multivariable logistic regression model illustrating the relationship between acute and chronic complications (defined as categorical out-
come variables (yes/no)) variability index and confounders in adult type 1 diabetic patients. N = 5545.
Severe
hypoglycemiaA
DKA Hypoglycemic
coma
HbA1cB Micro-
albuminuriaC
Macro-
albuminuriaD
Retinopathy Proliferative
retinopathy
Variability
Index
0.013, p = 0.001E 0.013,
p = 0.017
0.008, p = 0.116 -0.002,
p = 0.318
0.005,
p = 0.160
-0.003,
p = 0.729
-0.002,
p = 0.659
<-0.001,
p = 0.996
Age (years) 0.014, p = 0.001 0.008,
p = 0.159
0.022, p<0.001 -0.017,
p<0.001
0.016, p<0.001 0.023,
p = 0.010
0.015,
p = 0.001
0.008,
p = 0.163
Duration of
disease
(years)
0.010, p = 0.065 0.001,
p = 0.884
0.012, p = 0.106 0.003,
p = 0.241
0.023, p<0.001 0.030,
p = 0.003
0.088,
p<0.001
0.078, p<0.001
Sex (♀) -0.135, p = 0.227 0.205,
p = 0.154
-0.069, p = 0.645 -0.125,
p = 0.003
-0.268,
p = 0.005
-0.232,
p = 0.323
0.038,
p = 0.734
0.167,
p = 0.251
BR/kg/24h -0.254, p = 0.334 1.743,
p<0.001
0.119, p = 0.725 1.545,
p<0.001
0.932, p<0.001 0.011,
p = 0.984
0.239,
p = 0.322
0.476,
p = 0.121
Variability index indicates variation coefﬁcient in basal rate intervals (%), bold areas indicate signiﬁcant correlations.
A = severe hypoglycemia was blood glucose concentrations <70milligrams/deciliter + requirement of outside assistance.
B = HbA1c, corrected according to the Diabetes Control and Complications Trial (DCCT) was used for analysis
C = Microalbuminuria: persistent albumin excretion between 30 and 300 milligrams/24 hours
D = Macroalbuminuria: Albumin excretion above 300 mg/24 hours
E = beta-estimate and test probability, adjusted for age, sex, duration of disease and basal rates/kilogram/24 hours.
Abbreviations: DKA = diabetic ketoacidosis; HbA1c = glycated hemoglobin; BR = basal rates; kg = kilograms; h = hours
doi:10.1371/journal.pone.0150604.t003
Fig 1. Bar graphs illustrating the number of acute complications per quartile of the variability index.
doi:10.1371/journal.pone.0150604.g001
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Logistic regression analysis adjusted for age, gender, duration of disease and total basal insu-
lin confirmed significant positive correlations of VI with severe hypoglycemia (β = 0.013;
p<0.001) and diabetic ketoacidosis (β = 0.012; p = 0.017).
Discussion
The present study illustrates an association between higher individual variability in basal rates
and for a higher frequency of acute complications in T1DM patients treated by CSII (Fig 1). In
a cohort of approximately 5000 adult T1DM patients, higher variability in individual basal
rates correlated to an increased prevalence of severe hypoglycemia and diabetic ketoacidosis,
independent of total daily insulin, age, duration of disease, and gender. To the best of our
knowledge the association between BR variability and the frequency of acute diabetic complica-
tions is up to date unknown.
Which factors could explain our findings?
1. CSII allows for the programming of time-dependent insulin infusion rates. With the aim
of delivering insulin in a physiological manner, allegedly to account for circadian changes
in insulin-sensitivity.[4] Recently, Bouchonville et al. investigated whether programming
a nightly basal rate to counteract the dawn-phenomenon was successful or not. It was
found that CSII programming was neither associated with a reduction in the occurrence
nor with the magnitude of the dawn-phenomenon, but rather increased the risk of hypo-
glycemia.[3] Though, a higher variability of the BR to counteract the dawn-phenomenon
may be a possible explanation for the present results.
2. Another factor contributing to glucose variability in CSII may be insulin resorption.
Absorption of subcutaneously injected insulin is known to vary by 15–30%, depending on
drug quantity, subcutaneous blood flow, injection site, and composition of connective tis-
sue.[5–7] Also, the size of the subcutaneous insulin depot may play an important role in
subcutaneous pharmacokinetic.[8] Stable absorption and release of subcutaneously
injected insulin has been shown to improve glycemic control. Maybe higher variability
within BR causes fluctuations in insulin action potentially contributing to an increased
frequency of severe hypoglycemia in this analysis. However, inappropriate basal insulin
substitution correlates to recurrent and/or severe hypoglycemia as well as to chronic
hyperglycemia.[2] It is debatable whether the number of patients having insufficient insu-
lin resorption was large enough to co-create the illustrated effect of basal rate variation on
acute complications. Nevertheless, constraints in insulin resorption may increase glucose
variability in some T1DM patients.
3. In the present analysis, variations in basal rate patterns were associated with age, male
gender, duration of disease, and body mass index (BMI). This is in line with a retrospec-
tive analysis indicating that age increased the frequency of peaks and nadirs in basal rate
patterns.[1] Several studies confirm that insulin resistance is associated with the presence
of chronic complications, both micro- and macrovascular, and increased mortality in
T1DM patients.[9–12] Obesity and associated metabolic and hormonal traits are known
promoters of insulin resistance. Whereas BMI was lower in T1DM before the Diabetes
Control and Complications Trial was conducted, the percentage of overweight and obese
T1DM patients is close to 50% in adults and children nowadays.[10,13,14]
Male study participants had higher variations in basal rate patterns than female, and as men-
tioned above, inappropriate basal rates may promote acute hypoglycemia. A recent study
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illustrated gender differences in glycemic control and the burden of disease between male and
female T1DM patients. It was found that fear of hypoglycemia was more prevalent in women
compared to men.[15] Hereby, men could be less intimidated by hypoglycemic events and
therefore retain potentially inappropriate basal rates longer or more often than female T1DM
patients.
4. The present results can also be interpreted inversely. As is written below, the recom-
mended strategy to match basal CSII treatment to the patient’s requirements is to pro-
gram an estimated circadian profile. If acute complications (e.g. hypoglycemic events)
appear, the initial profile is adapted in a stepwise manner until ones individual insulin
requirements are met. The more adaptions are necessary, the higher is the chance that the
variability in one’s individual daily basal rate profile increases. Therefore, it cannot be
ruled out that our results represent patients that were more difficult to treat rather than
they reflect an association between BR variability and the prevalence of acute diabetic
complications.
5. Another conceivable scenario is the following: A high VI could identify patients who rely
on basal rate doses rather than bolus doses for the correction of glycemic variability. In
this scenario, those patients’ bolus regiments are inappropriate regarding correction or
carbohydrate doses, which would also lead to a higher chance for acute complications.
What are the clinical implications of these results?
The question remains to what extend a more constant basal rate is able to prevent acute com-
plications in T1DM. Notably, the present cross-sectional study is not able to answer the ques-
tion of how much does VI increase the risk for acute complications in T1DM. In addition,
there are no evidence-based recommendations available for the optimal basal rate patterns in
the treatment of adult T1DM.
It is not reasonable to expect that requirements for basal insulin will be met by a single “flat
rate” of insulin delivery, as circadian changes in counter-acting hormones and insulin sensitivity
are significant and predictable.[1,16] Finding the presumed optimal, initial basal rate pattern is
achieved by algorithms and fasting tests under controlled conditions.[17] Frequently used algo-
rithms that estimate individual basal rate requirements comprise for example Bode’s approach,
which uses up to four different basal rates per day, the constant basal rate pattern according to
Walsh, and Renner´s circadian basal rate profile.[18–20] Afterwards, the optimal individual
basal rate pattern is determined by stepwise titrations to address individual requirements due to
physiology, diet, physical activity, and self-experience. We also calculated VI for basal rat profiles
scheduled by the widely used Renner system. Renner´s approach creates a double peaked basal
rate profile that is thought to mirror circadian insulin requirements. The related VI was calcu-
lated by 36.9%, which is significantly higher than the VI of the actual basal rates in the present
study cohort. In clinical practice, Renner´s initial basal rate profiles have to be titrated with ongo-
ing duration of disease in order to account for individual, actual insulin requirements.
A higher variability within BR was found in T1DM patients who experienced a higher fre-
quency of severe hypoglycemic events. We suggest starting with a constant BR and, subse-
quently, to carefully adjust basal rate patterns to address individual needs depending on
patient-specific requirements.
The relevance of the present study is limited by the following: The study design is only able
to illustrate an association between the prevalence of complications and basal rate variability
but it does not allow for the identification of causative coherences. Also, the effect size achieved
in the present study does not inform about what fraction of the study population could benefit
Variability in Basal Rates in Type 1 Diabetes
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from reduced variability unless the study would indicate causation. The small effect size may
not just derive from a small effect in the correlation of variability in basal rates and the fre-
quency of acute complications, but could rather stem from a third, unmeasured variable that
weakly correlates with the measured variables.
The–presumably–most important limitation is the onetime measurement of VI, which does
not allow for identifying the direction, in which the variability points. In this cross-sectional
design we do not know whether a higher VI would even be beneficial in the same patient, if
measured prospectively. The most recent basal rate was used for analysis, including a time-
frame of ± 6 months prior and after data entry. This cross-sectional design may have yielded a
limited number of events (i.e. acute and chronic complications).
The strength of the study is the novelty of the findings. To the best of our knowledge this is
the first study, which could demonstrate an association of acute diabetic complications and
variability of BR. Another strength is the large number of patients analyzed in this study.
What kind of attention should we pay to these results?
The present results have to be interpreted with caution. On the one hand, a very simple
approach of how to measure basal rate variability correlated to the frequency of acute compli-
cations independent of numerous established confounding factors. On the other hand, the data
available arise from a registry, which collects anamnestic data. Registry data only reflect an
approximation of the real incidence of e.g. acute complications, depending on the quality of
the patient’s event diaries, memories and quality of the anamnesis during the visit.
The optimal cohort study to investigate whether basal rate variability does in fact increase
the incidence of diabetic complications would be longitudinal, randomized, and interventional.
With such a design, the net effect of BR variability could be determined in a controlled fashion,
though it´s not viable from an ethical point of view to withhold necessary adaptions in basal
rates from a cohort.
It cannot be assumed that–following the results of the present study–a majority of T1DM
patients on CSII would benefit from a flat basal rate in a way that they can avoid acute compli-
cations. First, registry data underlie the limitations described above and second, the effect size
of the present results is cannot be interpreted correctly without knowledge about causation.
Nevertheless, the effect was determined in a very large and well selected cohort, and was still
present in linear regression after multiple adjustments. In fact, experts in T1DM should neither
over-interpret nor ignore the results of the present study, as even though the study has several
limitations, the correlation was present in a very large cohort, reflecting the possibility that a
certain sub-cohort of T1DM patients could benefit from reduced variability in daily basal rates.
Conclusions
In conclusion, the present cross-sectional study is the first large-scale analysis illustrating an
association between higher variation in daily basal rates and the frequency of acute complica-
tions in T1DM. Higher variation in daily basal rates may identify patients who are more diffi-
cult to treat regarding glycemic goals in T1DM. A randomized trial would be necessary to
determine whether this association is causal, and whether reducing the variability of basal rates
can reduce acute complications in patients with T1DM.
Supporting Information
S1 Fig. Bar graphs illustrate the number of chronic complications per quartile of the vari-
ability index.
(TIF)
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